Roche Diagnostics International AG
Roche Diagnostics International AG, a leading entity in the global healthcare sector, is headquartered in Switzerland (CH). Founded in 1896, Roche has established itself as a pioneer in diagnostics, focusing on innovative solutions that enhance patient care. The company operates extensively across Europe, North America, and Asia, providing cutting-edge diagnostic tools and services. Roche's core offerings include molecular diagnostics, tissue diagnostics, and point-of-care testing, distinguished by their accuracy and reliability. The company is renowned for its commitment to research and development, which has led to significant advancements in personalised healthcare. With a strong market position, Roche Diagnostics is celebrated for its contributions to early disease detection and management, solidifying its reputation as a trusted leader in the diagnostics industry.
DitchCarbon Score
How does Roche Diagnostics International AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Roche Diagnostics International AG's score of 52 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Roche Diagnostics International AG's reported carbon emissions
In 2022, Roche Diagnostics International AG reported total greenhouse gas emissions of approximately 73,000 kg CO2e, which fall under Scope 1 and 2 emissions. This represents a significant reduction from 2004, when emissions were about 100,000 kg CO2e. The data indicates a commitment to lowering carbon emissions over time, although specific reduction targets or initiatives have not been disclosed. Roche Diagnostics is a current subsidiary of Roche Holding AG, which cascades its emissions data and climate commitments through corporate family relationships. The company is part of broader sustainability initiatives led by its parent organisation, F. Hoffmann-La Roche AG, which may include commitments to the Science Based Targets initiative (SBTi) and other climate-related frameworks. While no specific reduction targets have been outlined for Roche Diagnostics, the overall trend in emissions reduction suggests a proactive approach to climate commitments. The company continues to align with industry standards for greenhouse gas reporting and reduction strategies.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Roche Diagnostics International AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
